- Home
- RMT vs ATAI Comparison
RMT vs ATAI Comparison
Compare RMT & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMT
- ATAI
- Stock Information
- Founded
- RMT 1993
- ATAI 2018
- Country
- RMT United States
- ATAI Germany
- Employees
- RMT N/A
- ATAI N/A
- Industry
- RMT Investment Managers
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- RMT Finance
- ATAI Health Care
- Exchange
- RMT Nasdaq
- ATAI Nasdaq
- Market Cap
- RMT 460.2M
- ATAI 444.7M
- IPO Year
- RMT N/A
- ATAI 2021
- Fundamental
- Price
- RMT $9.45
- ATAI $4.13
- Analyst Decision
- RMT
- ATAI Strong Buy
- Analyst Count
- RMT 0
- ATAI 3
- Target Price
- RMT N/A
- ATAI $13.33
- AVG Volume (30 Days)
- RMT 111.5K
- ATAI 7.1M
- Earning Date
- RMT 01-01-0001
- ATAI 08-15-2025
- Dividend Yield
- RMT 7.37%
- ATAI N/A
- EPS Growth
- RMT N/A
- ATAI N/A
- EPS
- RMT 1.49
- ATAI N/A
- Revenue
- RMT N/A
- ATAI $1,863,000.00
- Revenue This Year
- RMT N/A
- ATAI $423.05
- Revenue Next Year
- RMT N/A
- ATAI N/A
- P/E Ratio
- RMT $6.18
- ATAI N/A
- Revenue Growth
- RMT N/A
- ATAI 572.56
- 52 Week Low
- RMT $7.67
- ATAI $1.03
- 52 Week High
- RMT $9.51
- ATAI $4.40
- Technical
- Relative Strength Index (RSI)
- RMT 50.97
- ATAI 69.30
- Support Level
- RMT $9.39
- ATAI $3.78
- Resistance Level
- RMT $9.55
- ATAI $4.25
- Average True Range (ATR)
- RMT 0.17
- ATAI 0.34
- MACD
- RMT -0.04
- ATAI 0.03
- Stochastic Oscillator
- RMT 53.39
- ATAI 79.85
About RMT Royce Micro-Cap Trust Inc.
Royce Micro-Cap Trust Inc is a diversified closed-end investment company. The company is engaged in investing in micro-cap securities. It invests in the consumer discretionary sector including auto components, automobiles, diversified consumer services, hotels, restaurants and leisure, household durables, internet and catalog retail, leisure products, media, multiline retail, textiles, apparels, and luxury goods, Consumer staples sector including beverages, food, and staples retailing, food products, and personal products, Energy sector including energy equipment and services, and oil, gas, and consumable fuels. The company also invests in other sectors including healthcare, financials, industrials, IT, telecommunications, and materials.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.